Latest Share Chat

ValiRx Share News (VAL)

ValiRx Information

Buy VAL Shares
Add VAL to Watchlist
Add VAL to Alert

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 3.25

Bid: 3.20

Ask: 3.30

Change: 0.00 (0.00%)

Spread: 0.10 (3.125%)

Open: 3.25

High: 3.25

Low: 3.25

Prev. Close: 3.25

Last checked at -

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Fri, 15th Nov 2013 10:28

LONDON (Alliance News) - Pharmaceutical company ValiRx PLC Friday said that it has raised GBP1 million in a placing of 307.7 million shares with institutional and other investors.

The cancer drug developer said that it will use the funds to further advance its development programmes.

The shares were priced at 0.325 pence per share. Following the placing, ValiRx has 2.0 million shares issued.

ValiRx shares were amongst the biggest decliners Friday morning, down 18% at 0.352 pence per share.

By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty

More News

24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

27 May 2020 14:20

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

7 May 2020 14:45

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

4 May 2020 16:18

Latest Share Chat

ValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Login to your account

Quickpicks are a member only feature

Login to your account